Merck & (MRK) Revenue — Quarter Ended Jun 30, 2025
Revenue for the quarter increased compared to the immediately preceding quarter. However, revenue declined relative to the same quarter one year earlier.
Key takeaway
Quarter ended Jun 30, 2025 · FY2025 Q2
Revenue for the quarter increased compared to the immediately preceding quarter. However, revenue declined relative to the same quarter one year earlier.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$15.8B
Revenue reported for this quarter.
Quarter-over-quarter
+1.8%
Change from the immediately preceding quarter.
Year-over-year
-1.9%
Change from the comparable year-ago quarter.
Trailing four quarters
$63.6B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Sep 30, 2024 | $16.7B | +4.4% |
| Dec 31, 2024 | $15.6B | +6.8% |
| Mar 31, 2025 | $15.5B | -1.6% |
| Jun 30, 2025 | $15.8B | -1.9% |
Revenue performance
The reported revenue direction is upward from the prior quarter, reversing the decline seen in the previous sequential period.
Quarterly comparison
Compared with the immediately preceding quarter, revenue rose. Compared with the same quarter one year earlier, revenue fell.
What to watch
Cash provided by operating activities decreased in the first six months compared with the same period a year earlier.